Entrada Therapeutics, Inc.

Invesco Ltd. TRDA
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/12/2026
Shares
41,926
Value ($000)
529
Weight
0.0%
2022 Q3 - 2026 Q1 (10 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).